Protein Kinase Cι Activity Is Necessary for Bcr-Abl-mediated Resistance to Drug-induced Apoptosis
Open Access
- 1 February 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (7), 3927-3930
- https://doi.org/10.1074/jbc.274.7.3927
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Herbimycin A accelerates the induction of apoptosis following etoposide treatment or γ-irradiation of bcr/abl-positive leukaemia cellsOncogene, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Structural and Signaling Requirements for BCR-ABL-Mediated Transformation and Inhibition of ApoptosisMolecular and Cellular Biology, 1995
- BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsBlood, 1995
- Apoptosis. Its significance in cancer and cancer TherapyCancer, 1994
- BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]Blood, 1994
- Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiateBlood, 1993
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973